Serum Levels of Calcitonin Gene-related Peptide and Substance P are Decreased in Patients with Diabetes Mellitus and Coronary Artery Disease

By Wang LH   Zhou SX   Li RC   Zheng LR   Zhu JH   Hu SJ   Sun YL  

The Journal of International Medical Research, Vol. 40, Iss. 1, 2012-01 ,pp. : 134-140

Field House Publishing

Access to resources Recommend Favorite

Efficacy and Pharmacokinetics of Gallopamil in Patients with Coronary Artery Disease

By Ferrara N.   Longobardi G.   Guerra N.   Nicolino A.   Acanfora D.   Furgi G.   Odierna L.   Rosiello R.   Rengo F.  

Pharmacological Research, Vol. 34, Iss. 1, 1996-07 ,pp. : 37-41

Academic Press

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibition Influences Serum Levels of Advanced Glycation End Products in Patients with Coronary Artery Disease: Results from a HOPE Substudy

By  

Heart Drug, Vol. 3, Iss. 2, 2003-08 ,pp. : 67-72

Karger

Access to resources Recommend Favorite

Pathophysiology and therapeutic modification of thrombin generation in patients with coronary artery disease

By Pothula A.   Serebruany V.L.   Gurbel P.   McKenzie M.E.   Atar D.  

European Journal of Pharmacology, Vol. 402, Iss. 1, 2000-08 ,pp. : 1-10

Elsevier

Access to resources Recommend Favorite

Perindopril: A Review of its Use in Patients With or at Risk of Developing Coronary Artery Disease

By Curran Monique P.   McCormack Paul L.   Simpson Dene  

Drugs, Vol. 66, Iss. 2, 2006-01 ,pp. : 235-255

Adis International

Access to resources Recommend Favorite